Myocardial iron overload in sickle/thalassemia patients of Italian origin

Myocardial iron overload in sickle/thalassemia patients of Italian origin

Detalhes bibliográficos
Main Authors:	Meloni Antonella, Ruffo Giovan, Keilberg Petra, D'Ascola Domenico, Quota Alessandra, Ascioti Claudio, Positano Vincenzo, Salvatori Cristina, Gulino Letizia, Lombardi Massimo, Pepe Alessia
Formato:	Artigo
Idioma:	English
Publicado em:	Elsevier 2013-01-01
Colecção:	Journal of Cardiovascular Magnetic Resonance

Registos relacionados

An automatic method for myocardial T2* curve fitting in thalassemia patients with severe iron overload
Por: Meloni Antonella, et al.
Publicado em: (2013-01-01)

Different patterns of myocardial iron overload by T2* Cardiovascular MR as markers of risk for cardiac complication in thalassemia major
Por: Meloni Antonella, et al.
Publicado em: (2012-02-01)

Reference ranges for biventricular volumes and ejection fraction and for left ventricular mass in adult thalassemia intermedia patients without myocardial iron overload
Por: Meloni Antonella, et al.
Publicado em: (2013-01-01)

Heart T2* for prediction of cardiac complications in well-treated thalassemia major patients
Por: Pepe Alessia, et al.
Publicado em: (2012-02-01)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
Por: Capra Marcello, et al.
Publicado em: (2011-02-01)

T2* heterogeneity detected by CMR could be related to myocardial iron distribution in Thalassemia patients
Por: Landini Luigi, et al.
Publicado em: (2009-01-01)

Different patterns of myocardial iron overload by multislice T2* Cardiovascular MR as markers of risk for cardiac dysfunction in thalassemia major
Por: Lombardo Massimo, et al.
Publicado em: (2011-02-01)

Diabetes mellitus and cardiac complications in thalassemia major patients
Por: Pepe Alessia, et al.
Publicado em: (2012-02-01)

Are the preferential patterns of myocardial iron overload preserved at the CMR follow-up?
Por: Meloni Antonella, et al.
Publicado em: (2012-02-01)

Safety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies
Por: Antonella Meloni, et al.
Publicado em: (2009-11-01)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipron-desferrioxamine versus deferasirox
Por: Borgna-Pignatti Caterina, et al.
Publicado em: (2011-02-01)

Preferential patterns of myocardial iron deposit by multislice multiecho T2* CMR in thalassemia major patients
Por: Ciancio Angela, et al.
Publicado em: (2010-01-01)

Right Ventricular Volumes and Function normalized to body surface area, age and sex in a large cohort of well-treated Thalassemia Major without myocardial iron overload
Por: Lombardi Massimo, et al.
Publicado em: (2011-02-01)

Left Ventricular Volumes, Mass and Function normalized to the body surface area, age and gender from CMR in a large cohort of well-treated Thalassemia Major patients without myocardial iron overload
Por: Lombardi Massimo, et al.
Publicado em: (2011-02-01)

MRI assessment of correlation between cardiac biventricular function, myocardial iron overload and pancreatic iron overload in a large cohort of thalassemia major patients
Por: Luciani Antongiulio, et al.
Publicado em: (2010-01-01)

Multiparametric Cardiac Magnetic Resonance Assessment in Sickle Beta Thalassemia
Por: Laura Pistoia, et al.
Publicado em: (2024-03-01)

Biventricular dimensions and function in pediatric sickle-cell disease and thalassemia major patients without cardiac iron
Por: Meloni Antonella, et al.
Publicado em: (2013-01-01)

Myocardial fibrosis by delayed enhancement cardiovascular magnetic resonance and HCV infection in thalassemia major patients
Por: Quarta Antonella, et al.
Publicado em: (2010-01-01)

Pregnancy in Thalassemia and Sickle Cell Disease: The Experience of an Italian Thalassemia Center
Por: Francesco Sorrentino, et al.
Publicado em: (2020-02-01)

Pancreatic Volume in Thalassemia: Determinants and Association with Alterations of Glucose Metabolism
Por: Antonella Meloni, et al.
Publicado em: (2025-02-01)

Deferiprone or deferasirox for cardiac siderosis in β thalassemia major (reply)
Por: Alessia Pepe, et al.
Publicado em: (2011-02-01)

N-terminal fragment of proBNP is a marker of risk for right ventricular dysfunction and cardiac complications in thalassemia major
Por: Ein Michele, et al.
Publicado em: (2010-01-01)

N-terminal fragment of proBNP is a marker of high cardiac output cardiomyopathy evaluated by CMR in thalassemia syndromes
Por: Ein Michele, et al.
Publicado em: (2010-01-01)

P1515: IMPACT OF GENOTYPE ON PANCREATIC IRON OVERLOAD AND IMPAIRED GLUCOSE METABOLISM IN THALASSEMIA MAJOR
Por: A. Meloni, et al.
Publicado em: (2022-06-01)

Biatrial and Biventricular Reference Ranges Based on Cardiac Magnetic Resonance in Sickle Cell Disease Patients Without Heart Damage
Por: Laura Pistoia, et al.
Publicado em: (2024-12-01)

Cardiac and pancreatic iron overload evaluation of sickle/β-Thalassemia patients utilizing T2* MRI
Por: Stark Pinhas, et al.
Publicado em: (2009-01-01)

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.
Por: Mariane de Montalembert, et al.
Publicado em: (2017-01-01)

Global longitudinal strain for detection of cardiac iron overload in patients with thalassemia: a meta-analysis of observational studies with individual-level participant data
Por: Armin Attar, et al.
Publicado em: (2022-08-01)

Current challenges in the management of patients with sickle cell disease – A report of the Italian experience
Por: Giovanna Russo, et al.
Publicado em: (2019-05-01)

Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study
Por: Maria Marsella, et al.
Publicado em: (2011-04-01)

Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders
Por: Emanuele Angelucci, et al.
Publicado em: (2008-05-01)

Oxidative Stress and Antioxidant Status in Adult Patients with Transfusion-Dependent Thalassemia: Correlation with Demographic, Laboratory, and Clinical Biomarkers
Por: Antonella Meloni, et al.
Publicado em: (2024-04-01)

Cramer-Rao lower bounds for precision in T2* assessment for myocardial iron overload measurements by T2* multi-echo CMR
Por: Tassi Cristina, et al.
Publicado em: (2010-01-01)

P1513: LOW VITAMIN D LEVELS ARE ASSOCIATED WITH INCREASED CARDIAC IRON UPTAKE IN THALASSEMIA MAJOR.
Por: A. Meloni, et al.
Publicado em: (2022-06-01)

Prevalence and clinical correlates of miocardial fibrosis and necrosis in thalassemia major patients by CMR-DE
Por: Valeri Gianluca, et al.
Publicado em: (2009-01-01)

P1456: MULTIPARAMETRIC CMR AND CARDIAC COMPLICATIONS IN THALASSEMIA INTERMEDIA
Por: Antonella Meloni, et al.
Publicado em: (2023-08-01)

Iron Overload in Sickle Cell Disease
Por: Radha Raghupathy, et al.
Publicado em: (2010-01-01)

Influence of genetic polymorphisms and mutations in the cardiac pathology of iron overload in thalassemia and sickle cell anemia patients: a retrospective study
Por: Veronica Agrigento, et al.
Publicado em: (2012-11-01)

Cardiac injury caused by iron overload in thalassemia
Por: Chunxi Fu, et al.
Publicado em: (2025-01-01)

Iron overload in non-transfusion-dependent thalassemia
Por: Khaled M. Musallam
Publicado em: (2013-03-01)